Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9460288Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Urology
NIH Funding · FY2025
Linked Award Amount
$2.2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#5,649
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Qi Cao as a PI. Multi-PI records show the full award amount for context.
- 5R01CA278832-02R01A novel role for EZH2 in A-to-I RNA editing in prostate cancer$655.3Kaward amount
- 1R01CA300246-01R01Combinational targeting histone and RNA modifications in prostate cancer$570.1Kaward amount
- 5R01CA285684-02R01A novel role for EZH2 in PARP regulation and PARPi-resistance in prostate cancer$567.2Kaward amount
- $428.7Kaward amount
Award organization
Organizations that administered FY2025 awards listing Qi Cao as a PI.
FY2025 award administered by Northwestern University (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNorthwestern University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7413
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #1577
- 2026Entered Top 10% NationallyRanked #1577
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Qi Cao.